Butterfly Network, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US1241551027
USD
3.06
0.09 (3.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.17 M

Shareholding (Mar 2025)

FII

9.87%

Held by 85 FIIs

DII

64.08%

Held by 32 DIIs

Promoter

5.09%

How big is Butterfly Network, Inc.?

22-Jun-2025

As of Jun 18, Butterfly Network, Inc. has a market capitalization of 544.04 million and reported net sales of 85.63 million, with a net profit loss of 64.70 million. Shareholder's funds are 168.83 million, and total assets amount to 256.08 million.

As of Jun 18, Butterfly Network, Inc. has a market capitalization of 544.04 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 85.63 million for the latest four quarters. During the same period, it experienced a net profit loss of 64.70 million.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds of 168.83 million and total assets amounting to 256.08 million.

Read More

What does Butterfly Network, Inc. do?

22-Jun-2025

Butterfly Network, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $21 million and a net loss of $14 million as of March 2025. It has a market cap of $544.04 million and does not pay dividends.

Overview:<BR>Butterfly Network, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 21 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -14 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 544.04 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.64 <BR>Return on Equity: -25.22% <BR>Price to Book: 2.27 <BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is Butterfly Network, Inc. overvalued or undervalued?

20-Sep-2025

As of March 29, 2021, Butterfly Network, Inc. is considered a risky investment due to its overvaluation, negative P/E ratio, poor return metrics, and significant underperformance compared to peers and the S&P 500.

As of 29 March 2021, the valuation grade for Butterfly Network, Inc. moved from does not qualify to risky, indicating a deterioration in its financial standing. The company appears to be overvalued, given its negative P/E ratio and poor return metrics. Key valuation ratios include a Price to Book Value of 2.56, an EV to EBIT of -6.89, and an EV to Sales of 5.38, all of which suggest significant challenges in generating profits relative to its valuation.<BR><BR>In comparison with peers, Butterfly Network's EV to EBITDA of -4.6501 is notably worse than Standard BioTools, Inc. at -3.0601, highlighting its relative underperformance. Additionally, while the stock has shown a strong 1-week return of 21.94% compared to the S&P 500's 1.05%, its year-to-date return of -39.42% starkly contrasts with the S&P 500's 12.22%, reinforcing the notion that the stock is struggling in the long term.

Read More

Is Butterfly Network, Inc. technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, Butterfly Network, Inc. has a neutral technical trend with mixed indicators, showing bullish signals on the weekly MACD and Bollinger Bands but mildly bearish daily moving averages, while the stock has outperformed the S&P 500 recently but underperformed year-to-date.

As of 31 October 2025, the technical trend for Butterfly Network, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed indicators influencing this position. The weekly MACD and Bollinger Bands are bullish, while the daily moving averages are mildly bearish. The KST shows a bullish signal on the weekly but is mildly bearish on the monthly. Dow Theory indicates a mildly bullish stance on both weekly and monthly time frames. <BR><BR>In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 19.09% and 12.45% respectively, but it has significantly underperformed over the year-to-date and longer time frames.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

The company has declared negative results in Mar'2025 after 3 consecutive positive quarters

  • INTEREST(9M) At USD 1.05 MM has Grown at 72.25%
2

Risky - Negative EBITDA

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 400 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.63

stock-summary
Return on Equity

-24.57%

stock-summary
Price to Book

1.72

Revenue and Profits:
Net Sales:
23 Million
(Quarterly Results - Jun 2025)
Net Profit:
-14 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
100.0%
0%
100.0%
6 Months
28.03%
0%
28.03%
1 Year
-7.55%
0%
-7.55%
2 Years
194.23%
0%
194.23%
3 Years
-11.3%
0%
-11.3%
4 Years
-52.19%
0%
-52.19%
5 Years
-80.6%
0%
-80.6%

Butterfly Network, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
31.85%
EBIT Growth (5y)
7.11%
EBIT to Interest (avg)
-132.04
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.64
Sales to Capital Employed (avg)
0.34
Tax Ratio
0.04%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
53.90%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.56
EV to EBIT
-6.89
EV to EBITDA
-8.12
EV to Capital Employed
5.29
EV to Sales
5.38
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-76.86%
ROE (Latest)
-25.22%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 38 Schemes (20.96%)

Foreign Institutions

Held by 85 Foreign Institutions (9.87%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 10.38% vs -5.36% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 1.43% vs 22.65% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "23.40",
          "val2": "21.20",
          "chgp": "10.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-12.00",
          "val2": "-15.40",
          "chgp": "22.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.30",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.40",
          "val2": "0.10",
          "chgp": "-1,500.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-13.80",
          "val2": "-14.00",
          "chgp": "1.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-603.60%",
          "val2": "-836.90%",
          "chgp": "23.33%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 24.58% vs -10.22% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 45.77% vs 20.75% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "82.10",
          "val2": "65.90",
          "chgp": "24.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-60.00",
          "val2": "-116.90",
          "chgp": "48.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.90",
          "val2": "-15.40",
          "chgp": "61.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-72.50",
          "val2": "-133.70",
          "chgp": "45.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-857.30%",
          "val2": "-1,906.60%",
          "chgp": "104.93%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
23.40
21.20
10.38%
Operating Profit (PBDIT) excl Other Income
-12.00
-15.40
22.08%
Interest
0.40
0.30
33.33%
Exceptional Items
-1.40
0.10
-1,500.00%
Consolidate Net Profit
-13.80
-14.00
1.43%
Operating Profit Margin (Excl OI)
-603.60%
-836.90%
23.33%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 10.38% vs -5.36% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 1.43% vs 22.65% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
82.10
65.90
24.58%
Operating Profit (PBDIT) excl Other Income
-60.00
-116.90
48.67%
Interest
1.30
0.00
Exceptional Items
-5.90
-15.40
61.69%
Consolidate Net Profit
-72.50
-133.70
45.77%
Operating Profit Margin (Excl OI)
-857.30%
-1,906.60%
104.93%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 24.58% vs -10.22% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 45.77% vs 20.75% in Dec 2023

stock-summaryCompany CV
About Butterfly Network, Inc. stock-summary
stock-summary
Butterfly Network, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available